• Amicus Therapeutics, Inc. (NASDAQ:FOLD) Given Consensus Recommendation of "Moderate Buy" by Analysts

    Source: Buzz FX / 09 Feb 2025 00:31:10   America/Chicago


    Amicus Therapeutics, Inc. (NASDAQ:FOLD) Given Consensus Recommendation of "Moderate Buy" by Analysts Written by MarketBeat February 9, 2025 Share Link copied to clipboard. Shares of Amicus Therapeutics, Inc.
    Read more...
Share on,